Topic Listing for EResearch Technology

Accounting Stock-based Compensation Acquire Make Investments Companies Technologies Cause Disruption Business
Action Governance Nominating Committee Action Nominating Committee
Administration Advertising Costs
Agreements Management Amendment Termination
Annual Meeting Attend Annual Meeting
Audit Committee Audit Committee Oversight
Audit Committee Report Audited Consolidated Financial Statements Available Http Proxydocscom Eres
Available Information Background
Basis Presentation Beneficial Ownership Reporting Compliance
Board Directors Committees Board Directors Meetings Committees
Board Directors Recommends Stockholders Vote Election Mckelvey Scheppmann Board Directors Recommends Stockholders Vote Election Morganroth Phillips
Bonus Plan Bruce Johnson
Business Combinations Business Combinations Valuation Intangible Assets
Business Seriously Harmed Dependence Limited Number Suppliers Candidates Election
Capacity Constraint System Failures Result Loss Liability Clients Cardiac Safety Equipment Own Lease Become Obsolete Due
Cardiac Safety Market Clinical Trials Cash Equivalents
Cautionary Statement Forward-looking Information Ceo Employment Agreement
Certain Relationships Related Party Transactions Change Vote After Return Proxy Card
Changes Internal Control Over Financial Reporting Clients
Clients Derive Substantial Revenue Therefore Loss Even Few Clinical Trial Sponsors Cros Not Shift Existing Paper-based
Code Ethics Business Conduct Compensation Committee
Compensation Committee Interlocks Insider Participation Compensation Committee Report
Compensation Directors Compensation Individual Named Executive Officers
Compensation Named Executive Officers Compensation Philosophy
Competition Comprehensive Income
Concentration Credit Risk Significant Clients Conclusions Regarding Disclosure Controls Procedures
Consent Independent Registered Public Accounting Firm Consolidated Balance Sheet Data
Consolidation Among Clients Cause Lose Decrease Market Products Contents
Contingencies Continuing Named Executive Officers
Controls Procedures Costs Revenues
Costs Solicitation Course Conducting Business Possess Deemed Personal Medical Information
Critical Accounting Policies Departure Directors Principal Officers Election Appointment
Depend Entirely Clinical Trial Market Downturn Cause Revenues Depreciation Amortization Long-lived Assets
Director Compensation Director Independence
Director Nominations Documents Incorporated Reference
Ede Elements Compensation
Eligibility Eligible Participants
Employees Entitled Vote Annual Meeting
Entry Material Definitive Agreement Erc
Eresearchtechnology Announces Appointment New Chief Financial Officer Eresearchtechnology Inc
Eresearchtechnology Inc Announces Pending Retirement Chief Executive Officer Eresearchtechnology Inc South 17th Street Philadelphia 19103
Eresearchtechnology Inc Subsidiaries Eresearchtechnology Inc Subsidiaries Consolidated Statements Operations Except Per
Eresearchtechnology Inc Subsidiaries Valuation Qualifying Accounts Eresearchtechnology Inc Updates Outlook Sets Earnings Conference Call
Eresearchtechnology Reports Results Eresnet
Estimates Event Unable Satisfy Regulatory Requirements Relating Internal Control
Executive Compensation Executive Overview
Exhibits Existing Equity Compensation Plans
Expert Extensive Governmental Regulation Clinical Trial Process Require Costly
Failure Continue Expand Business Manage Growth Successfully Disrupt Failure Establish Maintain Partnerships Other Strategic Alliances Delay
Failure Establish Maintain Strategic Alliances Delay Development Products Failure Expand Business Manage Growth Successfully Disrupt Operations
Fair Market Value Fair Value Disclosures Prior Sfas 123r Adoption
Fda Recommend Different Approach Measure Drug Effects Interval Federal Income Tax Consequences
Financial Statements Exhibits Foreign Currency Risk
Form 10-k Form 10-q
Form 8-k Future Operating Results Uncertain Fluctuate Fail Meet Expectations
General General Economic Conditions Fail Improve Continue Deteriorate Operations
General Economic Conditions Worsen Potential Clients Unwilling Make Goodwill
Goodwill Subject Impairment Result Significant Expense Governance Nominating Committee
Government Regulation Grants Plan Based Awards
Held 2008 Income Taxes
Incur Liability Result Providing Cardiac Safety Analysis Interpretation Incur Liability Result Providing Consulting Cardiac Safety Analysis
Indemnification Index
Index Consolidated Financial Statements Statement Schedule Inflation
Intellectual Property Interest Rate Risk
International Operations Expose Additional Risks Interruptions Delays Service Third-party Providers Impair Delivery Hosted
Introduction Issuer Purchases Equity Securities
Joseph Esposito Leases
Long-lived Assets Long-term Performance Awards
Managements Annual Report Internal Control Over Financial Reporting Managements Report Financial Statements
Managements Report Internal Control Over Financial Reporting Maximum Fair Market Value Incentive Stock Options
Net Income Per Common Share New Plan Benefits
Nominating Procedures Non-transferability Stock Option
Not Able Effectively Integrate Recent Transactions Historic Operations Not Successful Competing Against Others Providing Similar Product
Not Successful Competing Against Others Providing Similar Products Notice Annual Meeting Stockholders Held 2007
Operating Expenses Operating Segments Geographic Information
Operations Option Exercises
Option Price Options
Other Commitments Contingencies Other Income Net
Other Matters Overview
Part Part Other Information
Parties Claim Infringe Intellectual Property Rights Result Loss Parties Claims Damages Against Continue Result Unfavorable Settlement
Partnerships Pay Costs Soliciting Proxies Behalf Board Directors
Payment Manner Exercise Performance Shares
Period Stock Option Philadelphia
Potential Liability Insurance Principles Consolidation
Product Initiatives Project Assurance Implementation
Property Equipment Proposal
Proxy Statement Purpose
Qualified Performance-based Compensation Quantitative Qualitative Disclosures Market Risk
Quarterly Period 2006 Rapidly Changing Technology Impair Ability Develop Market Solutions
Ratification Independent Registered Public Accountants Ratification Independent Registered Public Accountants Proposal
Recent Accounting Pronouncements Recent Developments
Recent Pronouncements Recent Transactions
Reclassifications Registrants Telephone Number Including Area Code Securities Registered
Related Party Transactions Report Independent Registered Public Accounting Firm
Report Independent Registered Public Accounting Firm Internal Control Reports Revenue 176 Earnings Per Share 004
Reports Revenue 214 Earnings Per Share 004 Including Reports Revenue 254 Earnings Per Share 010
Repricing Without Stockholder Approval Research Development
Restricted Stock Restricted Stock Long-term Performance Awards Shares
Results Operations Financial Condition Revenue Recognition
Revenues Review External Data
Richard Baron Assume Duties Rights After Termination Employment
Risk Factors Role Compensation Committee
Role Compensation Committee Chief Executive Officer Sales Large Blocks Common Stock Cause Market Price
Sales Marketing Securities Exchange Act 1934
Several Large Clients Derive Substantial Revenue Therefore Loss Short-term Investments
Short-term Long-term Investments Signatures
Software Development Costs Software Products Complex Contain Undetected Errors Lead Increase
Special Executive Officers Registrant Stock Appreciation Rights
Stock Option Plans Stock Split
Stock Splits Stock-based Compensation
Stockholder Communications Board Directors Stockholder Proposals
Stockholder Return Performance Graph Stockholders Entitled Vote
Submission Matters Vote Security Holders Supplemental Cash Flow Information
Tax Consequences Tax Considerations
Tax Effect Related Share-based Compensation Expense Tax Effect Related Stock-based Compensation Expense
Technology Termination Material Definitive Agreement
Time Exercise Option Translation Foreign Financial Statements
Unable Protect Proprietary Technology Maintain Technological Advantages Lose United States Securities Exchange Washington 20549
United States Securities Exchange Washington 20549 Form 8-k Unregistered Sales Equity Securities Proceeds
Valuation Assumptions Options Granted Valuation Assumptions Options Granted 2006
Valuation Assumptions Options Granted 2006 2007 Vote Person
Vote Shares Held Street Name Voting
Voting Proxies Website
What Constitutes Quorum What Fail Instruct Broker
What Now What Purpose Annual Meeting
What Recommendations Board Directors What Vote Required
What Voting Rights Stockholders 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki